Citation 90497

CHANG,FR: HAYASHI,KI: CHEN,IH: LIAW,CC: BASTOS,KF: NAKANISHI,Y: NOZAKI,H: CRAGG,GM: WU,YC: LEE,KH:. (2003). ANTITUMOR AGENTS. 228. FIVE NEW AGAROFURANS, REISSANTINS A-E, AND CYTOTOXIC PRINCIPLES FROM REISSANTIA BUCHANNII.. 66(11)

Citation Details

Title	ANTITUMOR AGENTS. 228. FIVE NEW AGAROFURANS, REISSANTINS A-E, AND CYTOTOXIC PRINCIPLES FROM REISSANTIA BUCHANNII.
Authors	CHANG,FR: HAYASHI,KI: CHEN,IH: LIAW,CC: BASTOS,KF: NAKANISHI,Y: NOZAKI,H: CRAGG,GM: WU,YC: LEE,KH:
Year	2003
Volume	66
Issue	11

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Reissantia buchananii (HIPPOCRATEACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	REISSANTIN A	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN A	INACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	REISSANTIN B	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	WEAK ACTIVITY
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	INACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	WEAK ACTIVITY
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	INACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	INACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	WEAK ACTIVITY
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN B	INACTIVE
21	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	REISSANTIN C	None
22	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	REISSANTIN D	None
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	WEAK ACTIVITY
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	REISSANTIN D	INACTIVE
32	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESISSATNIN E	None
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	INACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	INACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	INACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	WEAK ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	INACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	INACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	INACTIVE
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESISSATNIN E	INACTIVE
42	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CELASTROL	None
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
52	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	None
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELA-1(10)-3-5-7-TETRAEN-29-OIC ACID,24-NOR: 3-HYDROXY-2-OXO: METHYL ESTER	ACTIVE
62	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PRISTIMEROL,6-OXO:	None
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	WEAK ACTIVITY
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	WEAK ACTIVITY
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	WEAK ACTIVITY
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	WEAK ACTIVITY
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	WEAK ACTIVITY
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	INACTIVE
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	INACTIVE
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	WEAK ACTIVITY
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMEROL,6-OXO:	WEAK ACTIVITY
72	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DATURADIONE,5-ALPHA:	None
73	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DATURADIONE,5-BETA:	None
74	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	None
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
82	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
83	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-ALPHA-3-BETA-HYDROXY:	WEAK ACTIVITY
84	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	None
85	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
86	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
87	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
88	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
89	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
90	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
91	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
92	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
93	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-ENONE,5-BETA-3-BETA-HYDROXY:	WEAK ACTIVITY
94	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FRIEDELAN	None
95	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FRIEDELAN-3-ONE,29-HYDROXY:	None
96	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FRIEDOOLEAN-29-AL,3-OXO:	None
97	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TETRACOSA-2-6-10-14-18-22-HEXAEN-1-OL,3-7-11-15-19-23-HEXAMETHYL:	None
98	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITOSTEROL,BETA:	None
99	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
100	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
101	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
102	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
103	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
104	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
105	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
106	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	WEAK ACTIVITY
107	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	EQUIVOCAL
108	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DAUCOSTEROL	None
109	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FERULIC ACID,TRANS: DOCOSYL ESTER	None
110	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FERULIC ACID,TRANS: LIGNOCERYL ESTER	None
111	Not specified	ISOLATION AND IDENTIFICATION OF	PYRIDINE-5-CARBOXYLIC ACID,N-METHYL-2-OXO-HYDRO: METHYL ESTER	None

Citation 90497

Citation Details

Summary

Organisms and Their Experiments (1)

Reissantia buchananii (HIPPOCRATEACEAE)

Show SPARQL Queries (1)

Query 1